Amphastar Pharma (AMPH) Stock Price, Quote & News

Company Profile

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable f...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 909 980 9484

Website: www.amphastar.com

Address:

11570 6th Street, Rancho Cucamonga, United States

EquityInvest Jul. 4 at 4:59 PM

AMPH Downgraded by B of A Securities -- Price Target Lowered to $10 $AMPH https://www.gurufocus.com/news/8936074/amph-downgraded-by-b-of-a-securities-price-target-lowered-to-20

0 · Reply

FutureCapitall Jun. 29 at 6:24 PM

$AMPH is facing renewed pressure, currently trading at $20.49. After a sharp Q1 2026 earnings miss, BofA Securities downgraded the stock to "Underperform" with a $20 price target, citing limited growth catalysts for the next 12-18 months. While the company is shifting toward proprietary drugs, investors are wary of the reliance on a slowing legacy business. Tread carefully; institutional sentiment remains fragile.

0 · Reply

EquityInvest Jun. 29 at 4:00 PM

BofA cuts Amphastar stock rating on limited growth visibility By Investing.com $AMPH https://www.investing.com/news/analyst-ratings/bofa-cuts-amphastar-stock-rating-on-limited-growth-visibility-93CH-4764835

0 · Reply

EquityInvest Jun. 11 at 12:04 AM

Does Xeris’ Strong Q1 2026 Rebound And Raised Outlook Change The Bull Case For XERS? - Simply Wall St $AMPH https://stocks.apple.com/AtiZI-jFhRx-yP_8Q3LJvBw

0 · Reply

MarketBeat Jun. 10 at 11:10 PM

https://marketbeat.com/a/8706100/ $AMPH Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth

0 · Reply

tradeordie24 Jun. 9 at 6:08 PM

$AMPH higher highs and higher lows push to $22+ tomorrow

2 · Reply

tradeordie24 Jun. 9 at 2:34 PM

$AMPH $22 inbound

1 · Reply

tradeordie24 Jun. 8 at 2:50 PM

$AMPH $22 soon

0 · Reply

tradeordie24 Jun. 8 at 11:47 AM

$AMPH breakout to $22?

0 · Reply

EquityInvest Jun. 5 at 2:49 PM

$AMPH i’m not letting this thing get above 20

0 · Reply

Amphastar downgraded to Underperform from Neutral at BofA

Jun 10, 2026, 9:15 AM EDT - 24 days ago

Amphastar Pharmaceuticals Transcript: 16th Annual East Coast IDEAS Conference

Jun 8, 2026, 8:19 AM EDT - 26 days ago

Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Jun 3, 2026, 4:55 PM EDT - 4 weeks ago

Amphastar Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 4:55 PM EDT - 4 weeks ago

Amphastar Pharmaceuticals Slides: FY 2026

2026-06-03T09:43:26.000Z - 4 weeks ago

Amphastar price target lowered to $20 from $23 at Barclays

Jun 1, 2026, 2:30 PM EDT - 4 weeks ago

Amphastar Pharmaceuticals Transcript: AGM 2026

May 27, 2026, 6:00 AM EDT - 5 weeks ago

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

2026-05-14T09:20:37.000Z - 7 weeks ago

Amphastar downgraded to Equal Weight from Overweight at Wells Fargo

May 13, 2026, 6:00 PM EDT - 7 weeks ago

Amphastar Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 6:00 PM EDT - 7 weeks ago

Amphastar Pharmaceuticals Slides: FY 2026

2026-05-11T12:55:10.000Z - 7 weeks ago

Amphastar price target lowered to $21 from $25 at Piper Sandler

2026-05-08T18:05:47.000Z - 2 months ago

Amphastar downgraded to Hold from Buy at Needham

2026-05-08T17:49:22.000Z - 2 months ago

Amphastar cut to Hold at Needham after ‘disappointing’ results

May 7, 2026, 5:00 PM EDT - 2 months ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 5:00 PM EDT - 2 months ago

Amphastar Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 5:00 PM EDT - 2 months ago

Amphastar Pharmaceuticals Slides: Q1 2026

May 7, 2026, 5:00 PM EDT - 2 months ago

Amphastar Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 2 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

May 6, 2026, 6:00 AM EDT - 2 months ago

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

Apr 30, 2026, 6:00 AM EDT - 2 months ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

2026-04-20T20:41:17.000Z - 2 months ago

Amphastar downgraded to Hold from Buy at Jefferies

Apr 14, 2026, 11:45 AM EDT - 2 months ago

Amphastar Pharmaceuticals Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 11:45 AM EDT - 2 months ago

Amphastar Pharmaceuticals Slides: 25th Annual Needham Virtual Healthcare Conference

Apr 13, 2026, 8:00 AM EDT - 2 months ago

Amphastar Pharmaceuticals Proxy statement: Proxy filing

Apr 13, 2026, 8:00 AM EDT - 2 months ago

Amphastar Pharmaceuticals Proxy statement: Proxy filing

2026-04-08T09:05:42.000Z - 3 months ago

Amphastar price target lowered to $23 from $30 at Barclays

Apr 6, 2026, 6:00 AM EDT - 3 months ago

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

Mar 10, 2026, 8:00 PM EDT - 4 months ago

Amphastar Pharmaceuticals Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 8:00 PM EDT - 4 months ago

Amphastar Pharmaceuticals Slides: Barclays 28th Annual Global Healthcare Conference

Mar 4, 2026, 6:00 AM EST - 4 months ago

Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference

2026-02-27T13:00:20.000Z - 4 months ago

Amphastar price target lowered to $30 from $34 at Wells Fargo

Feb 26, 2026, 5:00 PM EST - 4 months ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Amphastar Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Amphastar Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Amphastar Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 4:05 PM EST - 4 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025

2026-02-24T11:21:49.000Z - 4 months ago

Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA

Feb 24, 2026, 6:00 AM EST - 4 months ago

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

Feb 20, 2026, 6:00 AM EST - 4 months ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

Jan 14, 2026, 5:15 PM EST - 6 months ago

Amphastar Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 5:15 PM EST - 6 months ago

Amphastar Pharmaceuticals Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 6:00 AM EST - 6 months ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

2026-01-07T14:30:15.000Z - 6 months ago

Amphastar price target lowered to $30 from $31 at BofA

Jan 7, 2026, 6:00 AM EST - 6 months ago

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

2025-12-15T11:11:28.000Z - 7 months ago

Amphastar announces FDA approval for teriparatide injection

Dec 15, 2025, 6:00 AM EST - 7 months ago

Amphastar Announces FDA Approval for Teriparatide Injection

2025-12-08T21:32:03.000Z - 7 months ago

Amphastar initiated with an Equal Weight at Barclays

Dec 3, 2025, 2:00 PM EST - 7 months ago

Amphastar Pharmaceuticals Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 2:00 PM EST - 7 months ago

Amphastar Pharmaceuticals Slides: Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 6:00 AM EST - 7 months ago

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

Nov 19, 2025, 10:30 AM EST - 8 months ago

Amphastar Pharmaceuticals Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 10:30 AM EST - 8 months ago

Amphastar Pharmaceuticals Slides: FY 2025

Nov 12, 2025, 6:00 AM EST - 8 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Nov 6, 2025, 5:00 PM EST - 8 months ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Amphastar Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Amphastar Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

Amphastar Pharmaceuticals Slides: Q3 2025

Nov 6, 2025, 4:05 PM EST - 8 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

Oct 27, 2025, 6:00 AM EDT - 8 months ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

2025-10-09T12:35:56.000Z - 9 months ago

Amphastar price target lowered to $31 from $32 at BofA

Sep 3, 2025, 12:45 PM EDT - 10 months ago

Amphastar Pharmaceuticals Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 3, 2025, 12:45 PM EDT - 10 months ago

Amphastar Pharmaceuticals Slides: FY 2025

Aug 28, 2025, 6:00 AM EDT - 11 months ago

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

2025-08-26T10:35:09.000Z - 11 months ago

Amphastar price target raised to $32 from $28 at BofA

2025-08-12T10:50:52.000Z - 11 months ago

Amphastar announced FDA approval of iron sucrose injection

2025-08-12T10:50:46.000Z - 11 months ago

Needham upgrades Amphastar on valuation post AMP-002 approval

VTRS

Aug 12, 2025, 6:00 AM EDT - 11 months ago

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

Aug 11, 2025, 6:00 AM EDT - 11 months ago

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Amphastar Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Amphastar Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Amphastar Pharmaceuticals Slides: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 11 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

Jul 29, 2025, 6:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

Jul 14, 2025, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters

Jun 5, 2025, 2:00 PM EDT - 1 year ago

Amphastar Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 2:00 PM EDT - 1 year ago

Amphastar Pharmaceuticals Slides: FY 2025

May 14, 2025, 4:40 PM EDT - 1 year ago

Amphastar Pharmaceuticals Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 4:40 PM EDT - 1 year ago

Amphastar Pharmaceuticals Slides: FY 2025

May 9, 2025, 6:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

May 7, 2025, 5:00 PM EDT - 1 year ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Amphastar Pharmaceuticals Quarterly report: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Amphastar Pharmaceuticals Earnings release: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Amphastar Pharmaceuticals Slides: Q1 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Apr 30, 2025, 6:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals Proxy statement: Proxy Filing

Apr 9, 2025, 1:30 PM EDT - 1 year ago

Amphastar Pharmaceuticals Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 9, 2025, 1:30 PM EDT - 1 year ago

Amphastar Pharmaceuticals Slides: 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 6:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals Proxy statement: Proxy Filing

Mar 28, 2025, 6:00 AM EDT - 1 year ago

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Mar 12, 2025, 10:30 AM EDT - 1 year ago

Amphastar Pharmaceuticals Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 12, 2025, 10:30 AM EDT - 1 year ago

Amphastar Pharmaceuticals Slides: Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 6:00 AM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Feb 27, 2025, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Slides: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

Feb 20, 2025, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Jan 15, 2025, 2:15 PM EST - 1 year ago

Amphastar Pharmaceuticals Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 2:15 PM EST - 1 year ago

Amphastar Pharmaceuticals Slides: FY 2025

Jan 8, 2025, 6:00 AM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 11:30 AM EST - 1 year ago

Amphastar Pharmaceuticals Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Nov 20, 2024, 10:30 AM EST - 1 year ago

Amphastar Pharmaceuticals Transcript: Jefferies London Healthcare Conference 2024

Nov 20, 2024, 10:30 AM EST - 1 year ago

Amphastar Pharmaceuticals Slides: FY 2024

Nov 13, 2024, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Nov 6, 2024, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Amphastar Pharmaceuticals Slides: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Oct 29, 2024, 6:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Oct 2, 2024, 12:08 PM EDT - 1 year ago

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Sep 5, 2024, 10:15 AM EDT - 1 year ago

Amphastar Pharmaceuticals Transcript: 2024 Wells Fargo Healthcare Conference

Sep 5, 2024, 10:15 AM EDT - 1 year ago

Amphastar Pharmaceuticals Slides: FY 2024

Aug 28, 2024, 4:10 PM EDT - 2 years ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Amphastar Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Amphastar Pharmaceuticals Quarterly report: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Amphastar Pharmaceuticals Earnings release: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 2 years ago

Amphastar Pharmaceuticals Slides: Q2 2024

Aug 7, 2024, 4:05 PM EDT - 2 years ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Jul 31, 2024, 4:05 PM EDT - 2 years ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

EquityInvest Jul. 4 at 4:59 PM

AMPH Downgraded by B of A Securities -- Price Target Lowered to $10 $AMPH https://www.gurufocus.com/news/8936074/amph-downgraded-by-b-of-a-securities-price-target-lowered-to-20

0 · Reply

FutureCapitall Jun. 29 at 6:24 PM

0 · Reply

EquityInvest Jun. 29 at 4:00 PM

0 · Reply

EquityInvest Jun. 11 at 12:04 AM

Does Xeris’ Strong Q1 2026 Rebound And Raised Outlook Change The Bull Case For XERS? - Simply Wall St $AMPH https://stocks.apple.com/AtiZI-jFhRx-yP_8Q3LJvBw

0 · Reply

MarketBeat Jun. 10 at 11:10 PM

https://marketbeat.com/a/8706100/ $AMPH Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth

0 · Reply

tradeordie24 Jun. 9 at 6:08 PM

$AMPH higher highs and higher lows push to $22+ tomorrow

2 · Reply

tradeordie24 Jun. 9 at 2:34 PM

$AMPH $22 inbound

1 · Reply

tradeordie24 Jun. 8 at 2:50 PM

$AMPH $22 soon

0 · Reply

tradeordie24 Jun. 8 at 11:47 AM

$AMPH breakout to $22?

0 · Reply

EquityInvest Jun. 5 at 2:49 PM

$AMPH i’m not letting this thing get above 20

0 · Reply

MarketBeat Jun. 4 at 4:03 AM

https://marketbeat.com/a/8691230/ $AMPH Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag

0 · Reply

EquityInvest Jun. 3 at 2:03 PM

$AMPH $AMPH $AMPH In April 2026, the FDA classified the International Medication Systems (IMS) manufacturing facility in South El Monte, California—a subsidiary of Amphastar Pharmaceuticals—as Official Action Indicated (OAI). This classification follows a routine FDA facility inspection in December 2025 and indicates that the agency found objectionable conditions and recommends regulatory or administrative action.

0 · Reply

EquityInvest May. 29 at 7:08 PM

$AMPH $AMPH In April 2026, the FDA classified the International Medication Systems (IMS) manufacturing facility in South El Monte, California—a subsidiary of Amphastar Pharmaceuticals—as Official Action Indicated (OAI). This classification follows a routine FDA facility inspection in December 2025 and indicates that the agency found objectionable conditions and recommends regulatory or administrative action.

0 · Reply

ghfisch May. 22 at 2:08 PM

$AMPH sentiment right now is at 98 out of 100.. I think that's the highest I've ever seen for any stock

1 · Reply

EquityInvest May. 20 at 2:03 AM

$AMPH In April 2026, the FDA classified the International Medication Systems (IMS) manufacturing facility in South El Monte, California—a subsidiary of Amphastar Pharmaceuticals—as Official Action Indicated (OAI). This classification follows a routine FDA facility inspection in December 2025 and indicates that the agency found objectionable conditions and recommends regulatory or administrative action.

0 · Reply

NVDAMillionaire May. 19 at 11:45 PM

$AMPH Brilliant piece that captures AMPH's situation perfectly. So if you want to update your understanding of AMPH or get to know AMPH better, this is essential reading. https://everyticker.com/quote/AMPH/analysis/amphastar-s-manufacturing-moat-faces-its-moment-of-truth-can-proprietary-pipeline-offset-generic-erosion-nasdaq-amph

0 · Reply

Arcides May. 15 at 4:25 PM

$AMPH new 5 years low for this former IBD 50 stock...

0 · Reply

MarketBeat May. 14 at 6:06 AM

https://marketbeat.com/a/8653243/ $AMPH Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook

0 · Reply

Estimize May. 12 at 8:00 PM

Wall St is expecting 0.71 EPS for $AMPH Q2 [Reporting 08/10 AMC] http://www.estimize.com/intro/amph?chart=historical&metric_name=eps&utm_co

0 · Reply

EquityInvest May. 8 at 2:43 PM

$AMPH I love this company. shorting before earnings never fails 🤑😂😂💪

0 · Reply

JRZMike May. 8 at 10:56 AM

$AMPH what a shit show this stock has become

0 · Reply

StocktwitsEarnings May. 7 at 8:30 PM

$AMPH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.14 down -73.58% YoY • Reported revenue of $171.17M up 0.38% YoY

0 · Reply

Market Cap	865.99M
Revenue (ttm)	719.89M
Net Income (ttm)	98.09M
EPS (ttm)	N/A
PE Ratio	8.20
Forward PE	8.34
Profit Margin	13.63%
Debt to Equity Ratio	0.79

Volume	315,700
Avg Vol	653,962
Day's Range	N/A - N/A
Shares Out	44.09M
Stochastic %K	38%
Beta	0.89
Analysts	Hold
Price Target	$22.00